Ecuador's Trade Minister Briefs Guayaquil Business Leaders on the US Reciprocal Agreement

The Meeting

Luis Alberto Jaramillo, Ecuador's Minister of Production, Foreign Trade, Investment and Fisheries, met with business leaders at the Hotel Hilton Colón in Guayaquil on April 14, 2026 to walk through the details of the Reciprocal Trade Agreement (ART) between Ecuador and the United States. Per Expreso.

The meeting was hosted by the Cámara Ecuatoriano Americana de Comercio (Ecuadorian-American Chamber of Commerce), led by its president Nery Merejildo. Also present: Françoise Baramdyka, the US Consul General Chargée d'Affaires in Ecuador.

The minister's on-record statement:

"Esta fue una oportunidad para explicar a detalle el Acuerdo de Comercio Recíproco con EE. UU. y esclarecer dudas del sector empresarial."

(This was an opportunity to explain the US Reciprocal Trade Agreement in detail and clear up doubts from the business sector.)

What's in the Deal

Per Expreso, the ART "beneficiará al 57% de las exportaciones no petroleras" con arancel 0% — 57% of Ecuador's non-oil exports will enter the United States at zero tariff under the agreement.

Beyond tariff reduction, the agreement covers regulatory standards in three major sectors:

• Automotive (automotriz)
• Pharmaceutical (farmacéutico)
• Medical devices (dispositivos médicos)

And it establishes tariff-free quotas for three sensitive agricultural categories:

• Dairy (lácteos)
• Corn (maíz)
• Poultry (carne de ave)

The Concerns on the Business Side

The Expreso piece notes that two main concerns came up from the business sector during the briefing:

1. Competition with subsidized US agricultural products. This is the standard concern in any trade negotiation with the United States — American agriculture runs on substantial federal subsidies, which can make its products artificially cheap relative to non-subsidized Ecuadorian domestic producers.
2. Regulatory adjustment requirements. Complying with US-aligned standards in automotive, pharmaceutical, and medical device sectors is a real cost for Ecuadorian manufacturers. The question isn't whether those standards are reasonable — it's whether the transition period and support infrastructure are sufficient.

The article reports no specific next steps or implementation timeline.

How This Fits the Bigger Picture

This is a companion story to Ecuador's South Korea trade agreement approval on the same day (see our separate coverage). Together, they reflect a deliberate, multi-directional trade diversification push by the Noboa administration. The US deal is bigger in absolute terms; the South Korea deal is more structurally transformative for certain sectors (notably coastal shrimp).

What This Means for Expats

• If you run a business exporting from Ecuador to the US, now is the time to read the fine print. 57% tariff-free is a headline number, but it applies unevenly across product categories. Your HS code determines whether you benefit on day one or fall under a transition schedule. A trade lawyer or customs broker is the right investment before you make operational decisions.
• Dairy, corn, and poultry producers in Ecuador should be paying close attention. Tariff-free quotas mean defined volumes of US product entering at zero tariff. Above-quota shipments will face the existing tariff regime, but the quota itself is a meaningful new source of competition for domestic producers. Small Ecuadorian dairies and poultry operations will feel this first.
• The regulatory chapters on automotive, pharma, and medical devices may matter more than the tariff chapters. US-aligned standards open the door for US-based supply chains to operate in Ecuador — and make it easier for Ecuadorian producers to certify into the US market. Over time, that's a bigger deal than the 57% headline.
• If you are importing US products personally — cars, medications, consumer electronics — expect the effective landed cost of certain US goods to decline modestly over the next 12 months as the agreement phases in.
• Watch for the implementation timeline. The Expreso article notably does not report one. That omission usually means the agreement's entry into force hasn't been formally scheduled yet — which means the benefits are still prospective, not immediate.

Source: Expreso